Sexual & Men’s Health
PT-141 and Stress-Related Low Desire: What the Evidence Shows
No trial has tested PT-141 in people whose low sexual desire was caused by chronic stress. That is the honest answer to…
Does Sermorelin Affect Dopaminergic Activity Associated With Sexual Motivation?
The question in this article’s title — whether sermorelin affects dopaminergic activity associated with sexual motivation — packs at least three separate…
Can PT-141 Improve Autonomic Arousal Deficits in Neurological Sexual Disorders?
Short answer: no. PT-141 (bremelanotide) has not been shown to correct autonomic arousal deficits caused by neurological disease. Its single approval —…
How Effective Is PT-141 for Sexual Dysfunction Caused by Depression?
PT-141 has never been tested in people whose low libido comes from depression, and the label of the one approved product goes…
How does PT-141 address sexual dysfunction linked to depressive disorders?
The question in this article’s title carries a quiet assumption that deserves to be examined before we accept it. To ask how…
Does PT-141 Influence Neuroendocrine Pathways to Enhance Libido and Energy?
PT-141 (bremelanotide) has real randomised-trial evidence behind one effect and none behind the other one it gets credited with. The libido side…
PT-141 (Bremelanotide): How It Works, Results and Side Effects
The short answer. PT-141 (bremelanotide) works on the brain, not on blood flow. It activates melanocortin receptors in the central nervous system…
How PT-141 Supports Enhancing Sexual Desire and Sperm Performance in Clinical Trials?
PT-141 (bremelanotide) is FDA-approved for exactly one thing: acquired, generalized hypoactive sexual desire disorder in premenopausal women, sold as Vyleesi.1 No trial…
Can PT-141 Scientifically Improve Fatigue and Libido Dysregulation in Chronic Illnesses?
The question in this article’s title deserves an honest answer before the first section even begins: there is no approved use of…
Can PT-141 Enhance Blood Flow in Peripheral Artery Disease (PAD)?
Short answer: no — and it moves blood pressure the wrong way. There are no clinical trials of PT-141 (bremelanotide) in peripheral…